OKOMERA
Okomera is a biotech start-up that accelerates access to improved, precision-based cancer therapies. It pioneers automation and miniaturization of personalized tumor biopsy studies. This technology was invented and patented by Okomera's co-founders at Ecole Polytechnique. Aimee Wessel, Raphaël Tomas, Charles Baroud, and Sandra Jernström founded the Paris, Ile-de-France-based company in 2020.
OKOMERA
Industry:
Biotechnology Life Science Therapeutics
Founded:
2020-01-01
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.okomera.com
Total Employee:
1+
Status:
Active
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Content Delivery Network Euro Typekit OVH Squarespace
Similar Organizations
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
Aukera Therapeutics
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein related diseases.
T3 Pharmaceuticals
T3 Pharmaceuticals is to improve the lives of cancer patients with highly innovative treatments.
Current Advisors List
Current Employees Featured
Founder
Investors List
AGORANOV
AGORANOV investment in Non Equity Assistance - Okomera
Official Site Inspections
http://www.okomera.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
